EG20183A - Immunoassay for the simultaneous detection of HIV-1 HTLV2 HTLV-1 and HTLV-II-antibodies - Google Patents

Immunoassay for the simultaneous detection of HIV-1 HTLV2 HTLV-1 and HTLV-II-antibodies

Info

Publication number
EG20183A
EG20183A EG41892A EG41892A EG20183A EG 20183 A EG20183 A EG 20183A EG 41892 A EG41892 A EG 41892A EG 41892 A EG41892 A EG 41892A EG 20183 A EG20183 A EG 20183A
Authority
EG
Egypt
Prior art keywords
htlv
hiv
immunoassay
antibodies
htlv2
Prior art date
Application number
EG41892A
Other languages
English (en)
Inventor
Martial Lacroix
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Application granted granted Critical
Publication of EG20183A publication Critical patent/EG20183A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EG41892A 1991-07-29 1992-07-25 Immunoassay for the simultaneous detection of HIV-1 HTLV2 HTLV-1 and HTLV-II-antibodies EG20183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73707291A 1991-07-29 1991-07-29

Publications (1)

Publication Number Publication Date
EG20183A true EG20183A (en) 1997-09-30

Family

ID=24962471

Family Applications (1)

Application Number Title Priority Date Filing Date
EG41892A EG20183A (en) 1991-07-29 1992-07-25 Immunoassay for the simultaneous detection of HIV-1 HTLV2 HTLV-1 and HTLV-II-antibodies

Country Status (15)

Country Link
EP (1) EP0605433B1 (de)
JP (1) JP2931100B2 (de)
CN (1) CN1070484A (de)
AT (1) ATE132268T1 (de)
AU (1) AU2340992A (de)
CA (1) CA2114220A1 (de)
DE (1) DE69207200T2 (de)
EG (1) EG20183A (de)
ES (1) ES2085631T3 (de)
IE (1) IE922452A1 (de)
IL (1) IL102615A (de)
NZ (1) NZ243636A (de)
PT (1) PT100731B (de)
WO (1) WO1993003376A1 (de)
ZA (1) ZA925492B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125467C (en) * 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
JPH10502165A (ja) * 1994-05-31 1998-02-24 アボツト・ラボラトリーズ 合成ペプチド−改良イムノアッセイを使用する異なるｈｉｖ遺伝子型の検出
US5695930A (en) * 1994-11-10 1997-12-09 Weinstein; David E. HIV test kit method for detecting anti-HIV-I antibodies in saliva
US5977299A (en) * 1997-04-07 1999-11-02 Dade Behring Marburg Gmbh Activated peptides and conjugates
CA2288869A1 (en) * 1998-03-04 1999-09-10 Mary Ann Childs Rapid confirmatory test for microbial infections
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
CN103713127A (zh) * 2014-01-01 2014-04-09 武汉翰雄生物技术有限公司 一种人类嗜t细胞病毒酶联检测试剂盒
CN108241058A (zh) * 2018-01-13 2018-07-03 中国医学科学院医学生物学研究所 一种脊髓灰质炎病毒ⅲ型d抗原预包被检测方法及其检测试剂盒和应用
CN108387726A (zh) * 2018-01-13 2018-08-10 中国医学科学院医学生物学研究所 脊髓灰质炎病毒ⅰ、ⅱ、ⅲ型d抗原同步快速鉴别、定量检测方法及其检测试剂盒和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136798A3 (de) * 1983-08-25 1986-02-19 Biotech Research Laboratories Inc. Titrierungsplatte und Testsatz zum Nachweis von Antikörpern in menschlichem Serum und ihre Herstellung und Verwendung
US5039604A (en) * 1987-08-21 1991-08-13 Cellular Products, Inc. Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
DE69015708T2 (de) * 1989-01-13 1995-06-08 United Biomedical Inc., Lake Success, N.Y. Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1.

Also Published As

Publication number Publication date
EP0605433B1 (de) 1995-12-27
EP0605433A1 (de) 1994-07-13
IE922452A1 (en) 1993-02-10
DE69207200T2 (de) 1996-08-22
ES2085631T3 (es) 1996-06-01
IL102615A0 (en) 1993-01-14
IL102615A (en) 1997-04-15
DE69207200D1 (de) 1996-02-08
AU2340992A (en) 1993-03-02
JPH06509868A (ja) 1994-11-02
JP2931100B2 (ja) 1999-08-09
ZA925492B (en) 1993-04-28
WO1993003376A1 (en) 1993-02-18
CN1070484A (zh) 1993-03-31
ATE132268T1 (de) 1996-01-15
NZ243636A (en) 1993-06-25
PT100731A (pt) 1993-10-29
PT100731B (pt) 1999-07-30
CA2114220A1 (en) 1993-02-18

Similar Documents

Publication Publication Date Title
HK124293A (en) Diagnostic kit and method for rapid detection of antibodies
CA2033168A1 (en) Method of Optical Analysis
DE68919245D1 (de) Verfahren zum Nachweis von Endotoxin.
DE69022286D1 (de) Reagenzien, Verfahren und Testsätze zum Nachweis von Amphetaminen durch einen Fluoreszenz-Polarisations-Immunoassay.
BR0210598A (pt) Complexo solúvel que compreende uma glicoproteìna retroviral de superfìcie
SG77551A1 (en) Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing
ES2010316A6 (es) Dispositivo y equipo de ensayo y metodo de preparacion del mismo.
CA2022942A1 (en) Method of assessing sensitivity of hiv to zidovudine
EP0345462A3 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde
WO1999009410A3 (en) Rapid assay for simultaneous detection and differentiation of antibodies to hiv
ATE133206T1 (de) Verfahren zum nachweis von bakterien im harn
EG20183A (en) Immunoassay for the simultaneous detection of HIV-1 HTLV2 HTLV-1 and HTLV-II-antibodies
AU6727798A (en) Method for simultaneous detection of hiv antigens and hiv antibodies
CA2048655A1 (en) Discrimination between antibodies against htlv-1, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
NO874453L (no) Fremgangsmaate til bestemmelse av anti-hiv, middel dertil og dets anvendelse i fremgangsmaaten.
WO1990009594A3 (en) Wash composition, test kit and their use to determine a herpes simplex viral antigen
DE68919387D1 (de) DNS- und RNS-Proben, Methoden und Testsätze zum Nachweis von Salmonella.
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
SG49829A1 (en) Htlv-i and htlv-ii gp21 derived peptides for use in diagnostics
ATE130050T1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
DE69023500D1 (de) Verfahren zum nachweis von antikörpern gegen streptokinase.
ATE142342T1 (de) Benutzung von sp-2 monoklonalen antikörpern zur diagnostik und zur beobachtung des hiv- infektionsfortschritts